GSK Just Paid $10.6 Billion for This Precision Oncology Bet — Here’s What It Signals
The Nuvalent acquisition is the biggest biopharma deal of the week — and it’s rewriting the playbook for lung cancer investing.
The Nuvalent acquisition is the biggest biopharma deal of the week — and it’s rewriting the playbook for lung cancer investing.
June 11, 2026 Oracle Beat Earnings and Still Got Punished The numbers were good. The reaction was worse. Here is…
MRVL posted record revenue and a wave of analyst upgrades. The question is whether the tape has already priced the future.